The iStent inject® is intended to reduce intraocular pressure safely and effectively in patients diagnosed with primary open-angle glaucoma, pseudo-exfoliative glaucoma, or pigmentary glaucoma.

The iStent® is the smallest medical device ever approved by the FDA and is designed to treat mild-to-moderate open-angle glaucoma during cataract surgery procedures. The iStent® may help reduce a patient’s medication burden, reducing the cost, inconvenience, or side effects of using eye drops.